Literature DB >> 31073244

Bacteriophages of the lower urinary tract.

Andrea Garretto1, Taylor Miller-Ensminger1, Alan J Wolfe2, Catherine Putonti3,4,5,6.   

Abstract

The discovery of bacteria in the female urinary bladder has fundamentally changed current dogma regarding the urinary tract and related urinary disorders. Previous research characterized many of the bacterial components of the female urinary tract, but the viral fraction of this community is largely unknown. Viruses within the human microbiota far outnumber bacterial cells, with the most abundant viruses being those that infect bacteria (bacteriophages). Similar to observations within the microbiota of the gut and oral cavity, preliminary surveys of the urinary tract and bladder microbiota indicate a rich diversity of uncharacterized bacteriophage (phage) species. Phages are vital members of the microbiota, having critical roles in shaping bacterial metabolism and community structure. Although phages have been discovered in the urinary tract, such as phages that infect Escherichia coli, sampling them is challenging owing to low biomass, possible contamination when using non-invasive methods and the invasiveness of methods that reduce the potential for contamination. Phages could influence bladder health, but an understanding of the association between phage communities, bacterial populations and bladder health is in its infancy. However, evidence suggests that phages can defend the host against pathogenic bacteria and, therefore, modulation of the microbiome using phages has therapeutic potential for lower urinary tract symptoms. Furthermore, as natural predators of bacteria, phages have garnered renewed interest for their use as antimicrobial agents, for instance, in the treatment of urinary tract infections.

Entities:  

Mesh:

Year:  2019        PMID: 31073244      PMCID: PMC6800255          DOI: 10.1038/s41585-019-0192-4

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  16 in total

Review 1.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

Review 2.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

3.  In Vitro and In Vivo Assessments of Two Newly Isolated Bacteriophages against an ST13 Urinary Tract Infection Klebsiella pneumoniae.

Authors:  Fanny Laforêt; Céline Antoine; Bob Blasdel Reuter; Johann Detilleux; Jean-Paul Pirnay; Sylvain Brisse; Abdoulaye Fall; Jean-Noël Duprez; Véronique Delcenserie; Damien Thiry
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

4.  The Bladder is Not Sterile: an Update on the Urinary Microbiome.

Authors:  A Lenore Ackerman; Toby C Chai
Journal:  Curr Bladder Dysfunct Rep       Date:  2019-11-15

Review 5.  The human urobiome.

Authors:  L Brubaker; C Putonti; Q Dong; A J Wolfe
Journal:  Mamm Genome       Date:  2021-03-02       Impact factor: 2.957

Review 6.  Urinary Microbiome: Yin and Yang of the Urinary Tract.

Authors:  Virginia Perez-Carrasco; Ana Soriano-Lerma; Miguel Soriano; José Gutiérrez-Fernández; Jose A Garcia-Salcedo
Journal:  Front Cell Infect Microbiol       Date:  2021-05-18       Impact factor: 5.293

7.  Introducing Lu-1, a Novel Lactobacillus jensenii Phage Abundant in the Urogenital Tract.

Authors:  Taylor Miller-Ensminger; Rita Mormando; Laura Maskeri; Jason W Shapiro; Alan J Wolfe; Catherine Putonti
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

8.  Genome Sequence of Pseudomonas Phage UMP151, Isolated from the Female Bladder Microbiota.

Authors:  Genevieve Johnson; Catherine Putonti
Journal:  Microbiol Resour Announc       Date:  2019-08-15

9.  Completed Genomic Sequence of Bacillus thuringiensis HER1410 Reveals a Cry-Containing Chromosome, Two Megaplasmids, and an Integrative Plasmidial Prophage.

Authors:  Ana Lechuga; Cédric Lood; Margarita Salas; Vera van Noort; Rob Lavigne; Modesto Redrejo-Rodríguez
Journal:  G3 (Bethesda)       Date:  2020-09-02       Impact factor: 3.154

Review 10.  Viral Related Tools against SARS-CoV-2.

Authors:  Laura Fernandez-Garcia; Olga Pacios; Mónica González-Bardanca; Lucia Blasco; Inés Bleriot; Antón Ambroa; María López; German Bou; Maria Tomás
Journal:  Viruses       Date:  2020-10-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.